Main Advantages of Technology/Invention:
Current State of Development:
Further R&D Required:
Patent Status:
Contact Information:
John D. Hewes, Ph.D.,
Technology Transfer Center, NCI
Phone: 301-435-3121
E-mail: Hewesj@mail.nih.gov
This opportunity is also listed under the following categories:
Method For Effiecient Delivery Of Proteins Into Cells
Therapeutics To Treat Ocular Diseases
Monoclonal Antibodies Against B-Cell Chronic Lymphocytic Leukemia (B-CLL) Tumors
TTC maintains an e-mail service to notify you of new Collaborative Opportunities. If you would like to receive these emails, please sign up below. If you'd like to unsubscribe you can use this form as well.